Brief: Oncorus Inc - Announced Nomination Of Its First Synthetic Viral Rna Immunotherapy Clinical Candidates, Oncr-021 And Oncr-788
27/05/2021 12:30
May 27 (Reuters) - Oncorus Inc ONCR.O :
* ONCORUS INC - ANNOUNCED NOMINATION OF ITS FIRST SYNTHETIC
VIRAL
RNA IMMUNOTHERAPY CLINICAL CANDIDATES, ONCR-021 AND ONCR-788
* ONCORUS INC - PLANS TO FILE IND APPLICATION FOR ONCR-021
IN
FIRST HALF OF 2023
Source text for Eikon: ID:nGNX3Yp8qT
Further company coverage: ONCR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncorus
See all newsBrief: Oncorus Board Unanimously Approves Its Plan Of Dissolution, Liquidation
Brief: Oncorus Board Appoints Brian Shea As Interim CEO
U.S. STOCKS ON THE MOVE-Ford Motor, Theratechnologies, 3D Systems
Oncorus says no cash beyond Q3, cuts remaining jobs, shares tumble
Brief: Oncorus Announces Workforce Reduction Plan